• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy.

作者信息

Granowska M, Nimmon C C, Britton K E, Crowther M, Mather S J, Slevin M L, Shepherd J H

机构信息

Dept. of Nuclear Medicine, St Bartholomew's Hospital Medical College, West-Smithfield, London.

出版信息

J Nucl Med. 1988 May;29(5):599-607.

PMID:3373302
Abstract

Kinetic analysis with probability mapping is an objective method of serial image analysis applicable to radioimmunoscintigraphy. The technique is described and subjected to clinical testing by comparing the prediction of biopsy histology from the probability map in patients coming to operation. In those with ovarian cancer undergoing second-look laparotomy after completing full courses of chemotherapy, the prediction of histology in 108 biopsy sites was 45 true positives and 38 true negatives, sensitivity 80%, specificity 73%, accuracy 77% p less than 0.001. In patients with tumors less than 2 cm diameter, 41 biopsy sites were predicted with a specificity of 78% and an accuracy of 76%, p less than 0.01. The technique is reducing the need for second-look laparotomy in patients with subclinical and subradiological disease. Such disease is suitable for intraperitoneal radioimmunotherapy.

摘要

相似文献

1
Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy.
J Nucl Med. 1988 May;29(5):599-607.
2
Radioimmunoscintigraphy with Tc-99m-labelled SM3 in differentiating malignant from benign adnexal masses.用锝-99m标记的SM3进行放射免疫闪烁显像在鉴别附件肿块的良恶性方面的应用
BJOG. 2003 May;110(5):508-14.
3
A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer.123I 标记单克隆抗体成像在卵巢癌中的前瞻性研究。
J Clin Oncol. 1986 May;4(5):730-6. doi: 10.1200/JCO.1986.4.5.730.
4
Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours.放射性标记的脱蛋白黏蛋白SM3,用于卵巢肿瘤免疫闪烁显像的单克隆抗体。
Int J Biol Markers. 1990 Apr-Jun;5(2):89-96. doi: 10.1177/172460089000500208.
5
Radioimmunoscintigraphy of ovarian cancer.卵巢癌的放射免疫闪烁显像
Dis Markers. 1991 May-Aug;9(3-4):191-5.
6
Radioimmunoscintigraphy using monoclonal antibodies before second-look surgery in patients suffering from ovarian cancer.在卵巢癌患者二次探查手术前使用单克隆抗体进行放射免疫闪烁显像。
Gynecol Obstet Invest. 1987;24(3):211-6.
7
Primary diagnosis and follow-up of ovarian cancer: radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and "second look".卵巢癌的初步诊断与随访:用碘-131标记的OC 125单克隆抗体进行放射免疫闪烁显像与计算机断层扫描及“二次探查”的比较
Int J Rad Appl Instrum B. 1991;18(1):69-76. doi: 10.1016/0883-2897(91)90050-u.
8
[Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma].[与计算机断层扫描相比,放射免疫闪烁显像在原发性卵巢癌诊断及随访中的价值]
Rofo. 1990 Jul;153(1):85-91. doi: 10.1055/s-2008-1033338.
9
Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.
Eur J Nucl Med. 1989;15(1):42-8. doi: 10.1007/BF00253598.
10
[Visualization of malignant tumors in the abdomen using radiolabelled monoclonal antibodies].[使用放射性标记单克隆抗体对腹部恶性肿瘤进行可视化成像]
Geburtshilfe Frauenheilkd. 1984 Oct;44(10):623-6. doi: 10.1055/s-2008-1036319.

引用本文的文献

1
Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1.通过使用锝-99m人源化抗PEM单克隆抗体hHMFG1成像,在乳腺癌患者手术前评估腋窝淋巴结状态。
Br J Cancer. 2002 Mar 18;86(6):870-8. doi: 10.1038/sj.bjc.6600200.
2
99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection.99mTc标记的SM3在腋窝淋巴结和原发性乳腺癌术前评估中的应用,采用变化检测统计处理辅助肿瘤检测。
Br J Cancer. 1998;77(1):131-8. doi: 10.1038/bjc.1998.21.
3
Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer.
用锝-99m标记的单克隆抗体1A3进行的结直肠癌放射免疫闪烁显像。
Eur J Nucl Med. 1993 Aug;20(8):690-8. doi: 10.1007/BF00181760.
4
Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer.用99m锝标记的单克隆抗体SM3进行放射免疫闪烁显像在妇科癌症中的应用
Eur J Nucl Med. 1993 Jun;20(6):483-9. doi: 10.1007/BF00175160.
5
The present and future of radiolabelled antibodies in oncology.放射性标记抗体在肿瘤学中的现状与未来。
Ann Nucl Med. 1993 Aug;7(3):127-32. doi: 10.1007/BF03164955.
6
Inhibition of the hepatocyte uptake of radiolabelled monoclonal antibodies by chelating agents.螯合剂对放射性标记单克隆抗体肝细胞摄取的抑制作用。
Eur J Nucl Med. 1990;17(6-8):294-8. doi: 10.1007/BF01268018.
7
Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma.使用碘-131-B72.3单克隆抗体评估卵巢癌患者的治疗反应。
Eur J Nucl Med. 1991;18(4):269-73. doi: 10.1007/BF00186652.